/ /

  • linkedin
  • Increase Font
  • Sharebar

    Researchers, scientists flock to East Coast for ARVO 2017

    ‘Global Connections’ theme emphasizes scientific teamwork for advancing vision science

     

    All of the eye is a stage and immune cells are merely players

    Wednesday, 8:30 to 10:15 a.m.

    Our understanding of the function of immune cells as well as the faithful discrimination of their subpopulations in the eye has been an emerging area in eye research. How various immune cell types crosstalk with peripheral nerves, macroglia, blood-ocular barriers and neurons in the retina, and other cell types in the choroid has led to new discoveries in mechanisms that underpin the maintenance of the health of ocular tissues.

    Inflammaging and eye

    Wednesday, 8:30 to 10:15 a.m.

    This minisymposium of six presentations will provide a general view of the inflammation and age-related ocular diseases.

    Vision and driving: Lessons learned and future directions

    Wednesday, 8:30 to 10:15 a.m.

    This minisymposium will review research on vision and driving done from a variety of approaches including on-road driving assessments, driving monitoring systems, self-reported driving, records of motor vehicle collisions, and driving simulators. Speakers will discuss how vision or eye disease affect the ability to perform tasks related to safe driving.

    Membrane domains: Polarity, trafficking and assembly in the eye

    Wednesday, 11 a.m. to 12:45 p.m.

    The diverse and specialized cell types in the eye rely on highly organized and spatially restricted micron-scale and nanometer-scale sized membrane domains to perform their unique tissue functions. This minisymposium will focus on scaffolding and cytoskeletal molecules that assemble and stabilize membrane domains to control cell morphogenesis, organelle trafficking and polarity, cell shape and mechanics, cell-cell interactions, and tissue homeostasis.

    An eye on the eye microvasculature

    Wednesday, 3:45 to 5:30 p.m.

    Choroidal vessels play a relevant role in retinal and ocular homeostasis and their complex morphology and delicate balance can be perturbed by a number of factors often resulting in major pathological conditions. The minisymposium will bring together specialists in retinal microcirculation presenting state-of-the-art concepts of choroidal biology and function that will be useful for investigators of different ocular fields.

    The bench and the bedside: Who is the instructor?

    Wednesday, 3:45 to 5:30 p.m.

    This minisymposium will honor Robert Burton Nussenblatt, MD, a preeminent clinician-scientist in the field of inflammatory eye disease and past president of ARVO, who passed away in 2016. The session is based on the theme of Bench to Bedside (and back); i.e., how basic research instructs clinical practice and vice versa, a concept to which he devoted his professional career. Distinguished researchers representing a broad range of topics will present novel therapies in various stages of clinical development driven by strong basic and mechanistic studies in their respective fields.

     

    Visual functions and processes conserved across species

    Wednesday, 3:45 to 5:30 p.m.

    Whether through common ancestry or convergent evolution, the eyes of most vertebrate, and even some invertebrate species, are very similar anatomically. It is therefore logical that many visual functions or processes also might be conserved across the species. This minisymposium will provide examples of visual processes and functions that appear to be conserved across at least two species at different evolutionary levels.

    Saturday courses


    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results